FOCUS 3: A study to determine the feasibility of molecular selection of therapy using K-RAS, B-RAF, and topo-1 in patients with advanced colorectal cancer (ACRC).

被引：2
|
作者：
Maughan, Tim
Wilson, Richard H.
Williams, Geraint T.
Seymour, Matthew T.
Richman, Susan D.
Quirke, Philip
Pope, Janet
Pope, Malcolm
Parmar, Mahesh
Nelson, Annmarie
Meade, Angela M.
Nichols, Laura L.
Jasani, Bharat
Hodgkinson, Elizabeth
Fisher, David
Butler, Rachel
Bridgewater, John A.
Adams, Richard A.
Kaplan, Richard S.
机构：
[1] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England
[2] Queens Univ Belfast, Belfast, Antrim, North Ireland
[3] Cardiff Univ, Cardiff, Wales
[4] Univ Leeds, Leeds, W Yorkshire, England
[5] Velindre Canc Ctr, Cardiff, Wales
[6] MRC, Clin Trials Unit, London, England
[7] Wales Canc Trials Unit, Cardiff, Wales
[8] Cardiff Univ, Sch Med, Cardiff, Wales
[9] Weston Pk Hosp, Sheffield, S Yorkshire, England
[10] Inst Med Genet, Cardiff, Wales
[11] UCL, London, England
[12] Velindre Hosp, Cardiff, Wales
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
563
引用
收藏
页数：2
相关论文
共 4 条
  • [1] K-RAS AND B-RAF MUTATION AND CETUXIMAB THERAPY IN ADVANCED COLORECTAL CANCER PATIENTS : A RETROSPECTIVE MONOISTITUTIONAL STUDY.
    Frisinghelli, M.
    Soini, B.
    Ambrosini, G.
    Caffo, O.
    Caldara, A.
    Girlando, S.
    Barbareschi, M.
    Cuorvo, L., V
    Dalla Palma, P.
    Galligioni, E.
    ANNALS OF ONCOLOGY, 2009, 20
  • [2] Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients
    Georgieva, Milka
    Krasteva, Maria
    Angelova, Elka
    Ralchev, Krassimir
    Dimitrov, Valentin
    Bozhimirov, Stanislav
    Georgieva, Elena
    Berger, Martin R.
    ONCOLOGY REPORTS, 2008, 20 (01) : 3 - 11
  • [3] Epidermal growth factor (EGFR), K-Ras and B-Raf mutation status and clinical outcome to gefitinib (IRESSA) in a phase III placebo-controlled study (ISEL) in advanced non-small-cell lung cancer
    Holloway, B
    Thatcher, N
    Chang, A
    Parikh, P
    Pereira, JR
    Ciuleanu, T
    von Pawel, J
    Flannery, A
    Ellison, G
    Donald, E
    Knight, L
    Watkins, C
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9031S - 9032S
  • [4] Analysis of HER-3, insulin-growth factor-1 (IGF-1), nuclear factor k-B (NF-kB) and epidermal growth factor receptor (EGFR) gene copy number (GCN) in the prediction of clinical outcome for K-RAS wild type colorectal cancer patients receiving irinotecan-cetuximab
    Scartozzi, M.
    Giampieri, R.
    Maccaroni, E.
    Mandolesi, A.
    Giustini, L.
    Silva, R. R.
    Galizia, E.
    Falcone, A.
    Bearzi, I.
    Cascinu, S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S29 - S29
1